1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.1.1. Increasing Use of Microfluidic Immunoassays in Drug Discovery & Development and Biomarker Detection Driving Market Growth
4.2.1.2. Bubble Formation and Dead Volume Limiting the Adoption of Microfluidics Devices
4.2.1.3. Increasing Demand for Point-of-Care Testing Generating Growth Opportunities for Market Players
4.2.1.4. Selecting Suitable Substrate Materials to Design Microfluidic Chips to Remain a Major Challenge for Market Players
4.2.2. Factor Analysis
4.3. Technology Trends
4.3.1. Multiplexed Panel Detection
4.3.2. Paper-Based Microfluidics
4.4. Regulatory Analysis
4.4.1. North America
4.4.1.1. U.S.
4.4.1.2. Canada
4.4.2. Europe
4.4.3. Asia-Pacific
4.4.3.1. China
4.4.3.2. Japan
4.4.3.3. India
4.4.4. Latin America
4.4.5. Middle East
4.4.5.1. Saudi Arabia
4.5. Pricing Analysis
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Suppliers
4.6.2. Bargaining Power of Buyers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition
5. Microfluidic Immunoassay Market Assessment—by Product
5.1. Overview
5.2. Consumables
5.2.1. Cartridges
5.2.1.1. Polymer
5.2.1.2. Glass
5.2.1.3. Silicon
5.2.2. Reagents
5.3. Systems
6. Microfluidic Immunoassay Market Assessment—by Technology
6.1. Overview
6.2. Electrochemical Detection
6.3. Optical Detection
7. Microfluidic Immunoassay Market Assessment—by Application
7.1. Overview
7.2. Cardiology
7.2.1. Single Biomarker Detection
7.2.2. Multiplexed Biomarker Detection
7.3. Infectious Diseases
7.4. Oncology
7.5. Other Applications
8. Microfluidic Immunoassay Market Assessment—by End User
8.1. Overview
8.2. Pharmaceutical & Biotechnology Companies
8.3. Diagnostic Laboratories
8.4. Hospital
8.5. Other End Users
9. Microfluidic Immunoassay Market Assessment—by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.6. Middle East & Africa
10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
11. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)
11.1. Abbott Laboratories
11.2. Revvity, Inc. (Formerly PerkinElmer, Inc.)
11.3. Siemens Healthineers AG.
11.4. QuidelOrtho Corporation.
11.5. Nanomix, Inc.
11.6. Becton, Dickinson and Company
11.7. Micropoint Biotechnologies Co., Ltd.
11.8. Biosurfit SA
11.9. Koninklijke Philips N.V.
11.10. NanoEnTek Inc.
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Funding for Microfluidic Immunoassay Research & Development
Table 2 Estimated Number of New Cancer Cases, by Type (2020 Vs. 2030)
Table 3 Research Studies on Paper-Based Microfluidics, 2017–2023
Table 4 Authorities Regulating In Vitro Diagnostic Products, by Country/Region
Table 5 Medical Devices Regulatory Authorities in the Rest of APAC Countries
Table 6 Average Selling Prices of Microfluidic Immunoassay Products (USD/Unit)
Table 7 Quidelortho Corporation (U.S.): Product Pricing (USD/Unit)
Table 8 Abbott Laboratories (U.S.): Product Pricing (USD/Unit)
Table 9 Global Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
Table 10 Global Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
Table 11 Global Microfluidic Immunoassay Consumables Market, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
Table 13 Global Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Polymer-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Glass-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Silicon-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Microfluidic Immunoassay Reagents Market, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Microfluidic Immunoassay Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 19 Global Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
Table 20 Global Microfluidic Immunoassay Market for Electrochemical Detection, by Country/Region, 2021–2030 (USD Million)
Table 21 Optical Detection Techniques for Microfluidic Applications
Table 22 Global Microfluidic Immunoassay Market for Optical Detection, by Country/Region, 2021–2030 (USD Million)
Table 23 Global Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
Table 24 Clinically Significant Cardiac Biomarkers
Table 25 Global Microfluidic Immunoassay Market for Cardiology, by Type, 2021 2030 (USD Million)
Table 26 Global Microfluidic Immunoassay Market for Cardiology, by Country/Region, 2021–2030 (USD Million)
Table 27 Commercially Available Tests for Single Cardiac Biomarker Detection
Table 28 Global Microfluidic Immunoassay Market for Single Biomarker Detection, by Country/Region, 2021–2030 (USD Million)
Table 29 Commercially Available Tests for Multiplexed Cardiac Biomarker Detection
Table 30 Global Microfluidic Immunoassay Market for Multiplexed Biomarker Detection, by Country/Region, 2021–2030 (USD Million)
Table 31 Global Microfluidic Immunoassay Market for Infectious Disease, by Country/Region, 2021–2030 (USD Million)
Table 32 Clinically Significant Oncology Biomarkers
Table 33 Global Microfluidic Immunoassay Market for Oncology, by Country/Region, 2021–2030 (USD Million)
Table 34 Commercially Available Tests for Diabetes Biomarker Detection
Table 35 Global Microfluidic Immunoassay Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 36 Global Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
Table 37 Global Microfluidic Immunoassay Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021–2030 (USD Million)
Table 38 Global Microfluidic Immunoassay Market for Diagnostic Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 39 Global Microfluidic Immunoassay Market for Hospitals, by Country/Region, 2021–2030 (USD Million)
Table 40 Global Microfluidic Immunoassay Market for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 41 Global Microfluidic Immunoassay Market, by Country/Region, 2021-2030 (USD Million)
Table 42 North America: Microfluidic Immunoassay Market, by Country, 2021–2030 (USD Million)
Table 43 North America: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 44 North America: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 45 North America: Microfluidic Immunoassay Cartridges Market, by Material, 2021–2030 (USD Million)
Table 46 North America: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 47 North America: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 48 North America: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 49 North America: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 50 U.S.: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 51 U.S.: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 52 U.S.: Microfluidic Immunoassay Cartridges Market, by Material, 2021–2030 (USD Million)
Table 53 U.S.: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 54 U.S.: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 55 U.S.: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 56 U.S.: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 57 Canada: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 58 Canada: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 59 Canada: Microfluidic Immunoassay Cartridges Market, by Material, 2021–2030 (USD Million)
Table 60 Canada: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 61 Canada: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 62 Canada: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 63 Canada: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 64 Europe: Microfluidic Immunoassay Market, by Country/Region, 2021–2030 (USD Million
Table 65 Europe: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 66 Europe: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 67 Europe: Microfluidic Immunoassay Cartridges Market, by Material, 2021–2030 (USD Million)
Table 68 Europe: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 69 Europe: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 70 Europe: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 71 Europe: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 72 Germany: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 73 Germany: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 74 Germany: Microfluidic Immunoassay Cartridges Market, by Material, 2021–2030 (USD Million)
Table 75 Germany: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million
Table 76 Germany: Microfluidic Immunoassay Market, by Application, 2021–2030(USD Million)
Table 77 Germany: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 78 Germany: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 79 France: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 80 France: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 81 France: Microfluidic Immunoassay Cartridges Market, by Material, 2021–2030 (USD Million)
Table 82 France: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 83 France: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 84 France: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 85 France: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 86 U.K.: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 87 U.K.: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 88 U.K.: Microfluidic Immunoassay Cartridges Market, by Material, 2021–2030 (USD Million)
Table 89 U.K.: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 90 U.K.: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 91 U.K.: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 92 U.K.: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 93 Italy: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 94 Italy: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 95 Italy: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
Table 96 Italy: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 97 Italy: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 98 Italy: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 99 Spain: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 100 Spain: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 101 Spain: Microfluidic Immunoassay Cartridges Market, by Material, 2021–2030 (USD Million)
Table 102 Spain: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 103 Spain: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 104 Spain: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 105 Spain: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 106 Covid-19 Cases in European Countries
Table 107 Rest of Europe: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 108 Rest of Europe: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 109 Rest of Europe: Microfluidic Immunoassay Cartridges Market, by Material, 2021–2030 (USD Million)
Table 110 Rest of Europe: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 111 Rest of Europe: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 112 Rest of Europe: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 113 Rest of Europe: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 114 Asia-Pacific: Microfluidic Immunoassay Market, by Country/Region, 2021–2030 (USD Million)
Table 115 Asia-Pacific: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 116 Asia-Pacific: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 117 Asia-Pacific: Microfluidic Immunoassay Cartridges Market, by Material,2021–2030 (USD Million)
Table 118 Asia-Pacific: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 119 Asia-Pacific: Microfluidic Immunoassay Market, by Application, 2021–2030(USD Million)
Table 120 Asia-Pacific: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 121 Asia-Pacific: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 122 China: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 123 China: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 124 China: Microfluidic Immunoassay Cartridges Market, by Material, 2021–2030 (USD Million)
Table 125 China: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 126 China: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 127 China: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 128 China: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 129 Japan: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 130 Japan: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 131 Japan: Microfluidic Immunoassay Cartridges Market, by Material, 2021–2030 (USD Million)
Table 132 Japan: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 133 Japan: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 134 Japan: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 135 Japan: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 136 India: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 137 India: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 138 India: Microfluidic Immunoassay Cartridges Market, by Material, 2021–2030 (USD Million)
Table 139 India: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 140 India: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 141 India: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 142 India: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 143 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 144 Rest of Asia-Pacific: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 145 Rest of Asia-Pacific: Microfluidic Immunoassay Cartridges Market, by Material, 2021–2030 (USD Million)
Table 146 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 147 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 148 Rest of Asia-Pacific: Microfluidic Immunoassay Market for Cardiology, by Type, 2021 2030 (USD Million)
Table 149 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 150 Latin America: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 151 Latin America: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 152 Latin America: Microfluidic Immunoassay Cartridges Market, by Material, 2021–2030 (USD Million)
Table 153 Latin America: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 154 Latin America: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 155 Latin America: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 156 Latin America: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 157 Saudi Arabia, South Africa, and UAE Estimated Cancer Incidence
Table 158 Middle East & Africa: Microfluidic Immunoassay Market, by Product, 2021–2030 (USD Million)
Table 159 Middle East & Africa: Microfluidic Immunoassay Consumables Market, by Type, 2021–2030 (USD Million)
Table 160 Middle East & Africa: Microfluidic Immunoassay Cartridges Market, by Material, 2021 2030 (USD Million)
Table 161 Middle East & Africa: Microfluidic Immunoassay Market, by Technology, 2021–2030 (USD Million)
Table 162 Middle East & Africa: Microfluidic Immunoassay Market, by Application, 2021–2030 (USD Million)
Table 163 Middle East & Africa: Microfluidic Immunoassay Market for Cardiology, by Type, 2021–2030 (USD Million)
Table 164 Middle East & Africa: Microfluidic Immunoassay Market, by End User, 2021–2030 (USD Million)
Table 165 Recent Developments, by Company, 2020–2023
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Microfluidic Immunoassay Market, by Product, 2023 Vs. 2030 (USD Million)
Figure 8 Global Microfluidic Immunoassay Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 9 Global Microfluidic Immunoassay Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 10 Global Microfluidic Immunoassay Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 11 Microfluidic Immunoassay Market, by Geography
Figure 12 Impact Analysis of Market Dynamics
Figure 13 Global Pharmaceutical R&D Expenditure, 2012–2026 (USD Billion)
Figure 14 Eu Regulatory Pathway - IVDR 2017/746
Figure 15 Porter’s Five Forces Analysis
Figure 16 Global Microfluidic Immunoassay Market, by Product, 2023 Vs. 2030 (USD Million)
Figure 17 Global Microfluidic Immunoassay Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 18 Global Microfluidic Immunoassay Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 19 Global Microfluidic Immunoassay Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 20 Global Pharmaceutical R&D Spending, 2012–2026 (USD Billion)
Figure 21 Global Microfluidic Immunoassay Market, by Region, 2023 Vs. 2030 (USD Million)
Figure 22 North America: Number of People Aged 65 Years and Above, 2015–2021 (In Million)
Figure 23 North America: Microfluidic Immunoassay Market Snapshot
Figure 24 U.S.: Pharmaceutical R&D Expenditure, 2014–2021 (USD Billion)
Figure 25 Europe: Pharmaceutical Industry R&D Expenditure, 2000–2021 (USD Million)
Figure 26 Europe: Microfluidic Immunoassay Market Snapshot
Figure 27 U.K: Estimated Number of Cancer Cases, 2020–2030
Figure 28 Pharmaceutical R&D Expenditure, by Country, 2020 (USD Million)
Figure 29 Asia-Pacific: Microfluidic Immunoassay Market Snapshot
Figure 30 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 31 Microfluidic Immunoassay Market: Competitive Benchmarking (Based on Product)
Figure 32 Microfluidic Immunoassay Market: Competitive Benchmarking (Based on Geography)
Figure 33 Competitive Dashboard: Microfluidic Immunoassay Market
Figure 34 Abbott Laboratories: Financial Overview (2022)
Figure 35 PerkinElmer, Inc.: Financial Overview (2022)
Figure 36 Siemens Healthineers AG: Financial Overview (2022)
Figure 37 QuidelOrtho Corporation: Financial Snapshot (2022)
Figure 38 Nanomix, Inc.: Financial Overview (2022)
Figure 39 Becton, Dickinson and Company: Financial Overview (2022)
Figure 40 Koninklijke Philips N.V.: Financial Snapshot (2022)
Figure 41 NanoEnTek Inc.: Financial Snapshot (2022)
COVID-19
This report provides pre & post COVID-19 market estimates.